[ad_1]
Health
Reuters
An expert has discovered a problem facing the vaccine produced by the companies “Pfizer” and “Biontech” in the United States and Germany, which hinders its transportation and marketing.
Read more
And the British Press Association reported, citing an expert, that the Corona virus vaccine, which has been successfully tested by the two companies, must be stored at minus 70 degrees, which makes supply more difficult.
Gordon Dugan, a professor at the University of Cambridge, said many vaccines should be stored at “about four degrees or less,” but not minus 70 degrees, as required by the vaccine companies “Pfizer” and “Biontech”.
The professor said about it: “One can therefore imagine the delivery chain of this vaccine. It depends on the period after the vaccine is delivered to a specialist doctor, for example, as it can be stored in the room or at room temperature.”
On Monday, the German bioengineering company “Biontech” and the giant American pharmaceutical company “Pfizer” announced a successful third phase of clinical trials of the Coronavirus vaccine, which showed more than 90% efficacy in preventing infection. from “Covid-19”. An application for vaccine registration is expected to be made in the United States in November.
World Health Organization director-general Tedros Adhanom Ghebreyesus described the news on the vaccine trial results as encouraging.
Interestingly, two vaccines against Corona have been registered in Russia so far, the first of which is “Sputnik V”, developed by the “Gamalia” Epidemiological and Microbiological Research Center in collaboration with the Russian Direct Investment Fund, and the second vaccine is “Abiwak Corona” and developed by the specialist Victor Center. The two vaccines are now in post-registration testing.
A third vaccine was developed by the “Chumakov” Center for Research and Development of Immunomodulators of the Russian Academy of Sciences, and is now in clinical trials.
Source: Novosti
[ad_2]
Source link
